Dr. Mark T. Fleming is a board-certified medical oncologist with Virginia Oncology Associates (VOA). He received his medical degree from Medical University of Ohio. Dr. Fleming completed his residency at Temple University Hospital, Philadelphia, PA, and his Medical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center, New York, NY. See full bio here.

Dr. Leslie Busby is board-certified in hematology and medical oncology. He is medical director at Rocky Mountain Cancer Centers. Busby received his medical degree from The University of Nevada, School of Medicine, Reno, NV and completed his residency in internal medicine at the University of Missouri-Kansas City, Kansas City, MO. See full bio here.

Dr. Joe Buscema is a gynecologic oncologist who specializes in obstetrics and gynecology. He graduated from Johns Hopkins University School of Medicine. Dr. Buscema completed his residency and fellowship in gynecologic oncology at Johns Hopkins University. He has authored numerous articles on gynecologic cancer which have been published in Gynecologic Oncology, Obstetrics & Gynecology, the American Journal of Obstetrics & Gynecology Cancer, The Annual Review of Medicine, and The American Journal of Clinical Pathology. See full bio here.

Dr. Todd Doyle is a board-certified radiation oncologist practicing at New York Oncology and Hematology (NYOH). He received his medial degree from Albany Medical College and completed residencies in radiation oncology at the Mallinckrodt Institute of Radiology and Hospital of the University of Pennsylvania. See full bio here.

Dr. Audrey Garrett is medical director of gynecologic oncology at Willamette Valley Cancer Institute. She board-certified in gynecologic oncology, obstetrics and gynecology, palliative care medicine and received her medical degree and MPH from Columbia University. Garrett completed a fellowship and residency at Brigham and Women’s hospital, Harvard University. She is also a clinical assistant professor of obstetrics and gynecology at Oregon Health & Science University in Portland. See full bio here.

Dr. Amy McNally, MD is a Gynecologic Surgery Specialist in Saint Paul, MN and has over 21 years of experience in the medical field. She is board certified in gynecologic oncology and obstetrics and gynecology. McNally graduated from Creighton University School of Medicine medical school and completed a residency and fellowship at the University of Minnesota. See full bio here.

Dr. Timothy Murphy is a medical oncologist and hematologist with Rocky Mountain Cancer Centers (RMCC). He is board certified in medical oncology, internal medicine, hematology and FACP certified. Dr. Murphy completed residencies in internal medicine at Fitzsimons Army Medical Center, Aurora, CO and Walter Reed Army Medical Center, Washington, DC. Dr. Murphy also completed a hematology oncology fellowship at Walter Reed Army Medical Center, Washington, DC and a post-doctoral fellowship at Johns Hopkins University, Baltimore, MD. See full bio here.

Dr. Steven Paulson has served as president and chairman of Texas Oncology since 2000. He is a diplomat of the American Board of Internal Medicine. He is board certified. Dr. Paulson received his medical degree from The University of TX Southwestern Medical School. He received training at Harvard Medical School, at Peter Brent Brigham Hospital, and completed training at Parkland Memorial Hospital, where he also did a fellowship. Dr. Paulson received additional training at the Bone Marrow Transplant Unit at Fred Hutchinson Cancer Center. See full bio here.

Dr. Alex Spira, a graduate of Harvard University, earned his medical degree from the NY University School of Medicine. He completed his internship and residency at the Hospital of the University of PA, completed his fellowship at Johns Hopkins Hospital and received his PhD from the NY University School of Arts & Science. He is the Director of the VCS Research Institute and Phase I Trial Program and serves as medical director for the Inova Thoracic Oncology Program and as chair of The Network Pathways Committee for lung cancer. See full bio here.

Dr. Schwerkoske has been President of Minnesota Oncology since 2019. He is board certified in internal medicine, medical oncology and hematology and specializes in brain tumors and hematologic malignancies. He earned his medical degree from Ohio State University and completed his residency at Case Western Reserve in Cleveland, Ohio. Dr Schwerkoske has co-authored several professional papers that reflect his interest in cancers of the brain and breast, as well as hematologic malignancies and autologous stem cell transplantation. See full bio here.

Dr. Ira Zackon is director of the New York Oncology Hematology Stem Cell Transplant Program and sits on the NYOH Board of Directors. He is board certified in internal medicine, medical oncology, and hematology. He received his medical degree from McGill University Montreal. He completed his internship and residency in internal medicine at Royal Victoria Hospital, McGill University. He completed his fellowship at Dartmouth-Hitchcock Medical Center and his research fellowship at Northwestern University Medical. See full bio here.